What are the appropriate dosing schedules for flucloxacillin, dicloxacillin, clindamycin, cephalexin, erythromycin, and intravenous flucloxacillin for skin and soft tissue infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Antibiotic Dosing for Skin and Soft Tissue Infections

For uncomplicated skin and soft tissue infections in adults, use cephalexin 500 mg every 12 hours, dicloxacillin 250 mg every 6 hours, or clindamycin 300-450 mg every 8 hours orally; for severe infections requiring IV therapy, use flucloxacillin 1-2 g every 6 hours or clindamycin 600-900 mg every 8 hours intravenously.

Oral Antibiotic Dosing

Cephalexin (First-Line for Mild-Moderate Infections)

  • Adults: 500 mg every 12 hours for uncomplicated skin infections 1
  • Alternative: 250 mg every 6 hours for milder cases 1
  • Pediatric: 25-50 mg/kg/day divided every 12 hours (can divide every 6 hours for severe infections) 1
  • Maximum daily dose: 4 g 1
  • Duration: 7-10 days (minimum 10 days for streptococcal infections) 1

Clinical Pearl: The 500 mg twice-daily dosing enhances compliance compared to four-times-daily regimens and shows equivalent efficacy 2. However, recent PK/PD data suggest higher doses may be needed for moderate-severe infections, especially those caused by S. aureus 3.

Dicloxacillin (For Staphylococcal Infections)

  • Adults - Mild to Moderate: 125 mg every 6 hours 4
  • Adults - Severe: 250 mg every 6 hours 4
  • Pediatric (<40 kg):
    • Mild-moderate: 12.5 mg/kg/day divided every 6 hours 4
    • Severe: 25 mg/kg/day divided every 6 hours 4
  • Critical: Must take on empty stomach (1 hour before or 2 hours after meals) with at least 120 mL water 4
  • Avoid taking supine or before bed 4

Flucloxacillin (Oral - Alternative to Dicloxacillin)

  • Dosing similar to dicloxacillin based on pharmacokinetic equivalence 5
  • Can be given twice daily with probenecid for chronic infections: 1-2 g twice daily 6
  • Shows similar protein binding (94.7-96.2%) and serum bactericidal titers to dicloxacillin 5

Clindamycin (For Penicillin Allergy or MRSA Coverage)

  • Adults: 300-450 mg every 8 hours orally 7
  • Alternative dosing from research: 300 mg three times daily 7
  • Pediatric: 10-13 mg/kg/dose every 8 hours 8
  • Effective for both streptococcal and staphylococcal infections 7

Erythromycin

  • Not specifically dosed in the provided evidence for SSTIs
  • Generally reserved for penicillin-allergic patients
  • Caution: Risk of inducible resistance in MRSA 8

Intravenous Antibiotic Dosing (Severe/Necrotizing Infections)

IV Flucloxacillin (or Nafcillin/Oxacillin)

  • Adults: 1-2 g every 4 hours IV 8
  • Pediatric: 50 mg/kg/dose every 6 hours IV 8
  • Use for severe staphylococcal infections including necrotizing fasciitis 8

IV Clindamycin

  • Adults: 600-900 mg every 8 hours IV 8
  • Pediatric: 10-13 mg/kg/dose every 8 hours IV 8
  • Critical for necrotizing infections: Always combine with penicillin for streptococcal necrotizing fasciitis (penicillin 2-4 million units every 4-6 hours) 8
  • Clindamycin inhibits toxin production—essential for severe streptococcal infections 8

Vancomycin (For MRSA)

  • Adults: 15 mg/kg every 12 hours IV (30 mg/kg/day in 2 divided doses) 8
  • Pediatric: 15 mg/kg/dose every 6 hours IV 8
  • Use when MRSA suspected or confirmed 8

Treatment Duration and Key Considerations

Standard Duration

  • Minimum: Continue for 48 hours after patient becomes afebrile and asymptomatic 4
  • Typical: 7-10 days for uncomplicated infections 1, 9
  • Streptococcal infections: Minimum 10 days 1
  • Severe staphylococcal infections: At least 14 days 4
  • Endocarditis/osteomyelitis: Prolonged therapy required 4

Critical Pitfalls to Avoid

  1. Empty stomach requirement for dicloxacillin/flucloxacillin: Absorption significantly reduced with food 4

  2. Inadequate dosing for moderate-severe infections: The FDA-approved 500 mg twice-daily cephalexin may be suboptimal for S. aureus in moderate-severe infections; consider higher doses or alternative agents 3

  3. Inappropriate antibiotic selection: Nearly 50% of patients receive inappropriate antibiotics, especially for purulent infections where MRSA coverage is needed 10. For purulent abscesses, incision and drainage is primary; if antibiotics needed, use MRSA-active agents (clindamycin, doxycycline, or trimethoprim-sulfamethoxazole)

  4. Delaying surgical intervention: For necrotizing fasciitis, early surgical debridement is life-saving—antibiotics alone are insufficient 8

  5. Monotherapy for necrotizing infections: Always use combination therapy (beta-lactam + clindamycin) for suspected streptococcal necrotizing fasciitis 8

Algorithm for Antibiotic Selection

Mild-Moderate Non-Purulent Cellulitis (presumed streptococcal):

  • First choice: Cephalexin 500 mg PO q12h 1
  • Alternative: Dicloxacillin 125-250 mg PO q6h 4
  • Penicillin allergy: Clindamycin 300-450 mg PO q8h 7

Purulent Infections/Suspected MRSA:

  • Clindamycin 300-450 mg PO q8h (after I&D) 8

Severe Infections Requiring Hospitalization:

  • Methicillin-susceptible: Nafcillin/oxacillin 1-2 g IV q4h 8
  • MRSA or penicillin allergy: Vancomycin 15 mg/kg IV q12h 8

Necrotizing Fasciitis (requires immediate surgery):

  • Streptococcal: Penicillin 2-4 million units IV q4-6h + clindamycin 600-900 mg IV q8h 8
  • Staphylococcal: Nafcillin 1-2 g IV q4h or vancomycin 15 mg/kg IV q12h 8
  • Polymicrobial: Piperacillin-tazobactam 3.37 g IV q6-8h + vancomycin 8

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.